Aptamer Group PLC (AIM:APTA)

Market Cap	16.86M +168.7%
Revenue (ttm)	1.38M +13.4%
Net Income	-2.46M
EPS	-0.00
Shares Out	2.70B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,314,243
Average Volume	5,218,601
Open	0.6075
Previous Close	0.6500
Day's Range	0.6000 - 0.6500
52-Week Range	0.2311 - 1.5700
Beta	0.70
RSI	17.34
Earnings Date	Mar 30, 2026

About Aptamer Group

Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and analytical, bioprocessing, diagnostic, cosmetic and consumer health, and therapeutic applications. The company serves pharmaceutical, diagnostic, and b...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 31
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: APTA

Financial Performance

In fiscal year 2025, Aptamer Group's revenue was 1.20 million, an increase of 39.88% compared to the previous year's 860,000. Losses were -2.42 million, -18.05% less than in 2024.